Related Experiment Videos
Circulating endothelial cell/leucocyte adhesion molecules in ischaemic heart disease
A D Blann1, J Amiral, C N McCollum
1Department of Surgery, University Hospital of South Manchester, Didsbury, U.K.
British Journal of Haematology
|November 1, 1996
Summary
Patients with ischemic heart disease show elevated endothelial markers like soluble E-selectin, soluble thrombomodulin, and von Willebrand factor (VWF). These markers correlate with atherosclerosis risk factors, suggesting distinct roles in coronary artery disease.
Area of Science:
- Cardiovascular Medicine
- Biomarkers
- Endothelial Biology
Background:
- Endothelial dysfunction is a key factor in ischemic heart disease (IHD).
- Specific endothelial markers may indicate disease presence and progression.
- Understanding these markers' release mechanisms is crucial for IHD research.
Purpose of the Study:
- To compare levels of soluble E-selectin, soluble thrombomodulin, and von Willebrand factor (VWF) in patients with IHD versus controls.
- To investigate the correlation between these endothelial markers and major atherosclerosis risk factors.
Main Methods:
- Cross-sectional study comparing 116 IHD patients with 116 age- and sex-matched controls.
- Measurement of serum levels for soluble E-selectin, soluble thrombomodulin, and VWF.
- Multivariate analysis to assess marker associations with risk factors (cholesterol, triglycerides, sex).
Main Results:
- Significantly higher levels of soluble E-selectin, soluble thrombomodulin, and VWF were observed in IHD patients.
- VWF levels correlated positively with total cholesterol.
- Soluble E-selectin levels showed correlation with sex and triglyceride levels.
Conclusions:
- Distinct release mechanisms for soluble E-selectin, soluble thrombomodulin, and VWF are suggested.
- These endothelial markers may play differential roles in the pathophysiology of coronary artery disease.
- Further research is warranted to elucidate the specific contributions of these molecules to IHD.